Search results for "Venous thromboembolism"
Model predicts 30-day mortality after acute PE using simple clinical variables
A simple model to predict 30-day mortality after acute pulmonary embolism (PE) works as well as the European Society of Cardiology (ESC) model, yet doesn't require routine imaging or biomarker testing like the latter does, a study found.
https://acphospitalist.acponline.org/weekly/archives/2011/08/31/2.htm
31 Aug 2011
VTE readmissions continue more than 30 days after complex cancer surgery
In a retrospective cohort study using U.S. data from 2016, 0.6%, 1.1%, and 1.7% of patients undergoing complex cancer surgery were readmitted with VTE as a primary diagnosis by 30, 90, and 180 days after discharge.
https://acphospitalist.acponline.org/archives/2022/02/02/vte-readmissions-continue-more-than-30-days-after-complex-cancer-surgery.htm
2 Feb 2022
More severe heart failure patients have higher VTE risk
Inpatients with more severe heart failure are at higher short-term risk of venous thromboembolism (VTE) than those with less severe heart failure, an analysis found.
https://acphospitalist.acponline.org/weekly/archives/2014/07/09/3.htm
9 Jul 2014
Apixaban may prevent or shorten rehospitalizations for acute VTE, study finds
After VTE, study patients were randomized to apixaban, 10 mg twice daily for the first 7 days followed by 5 mg twice daily for 23 weeks or enoxaparin, 1 mg/kg of body weight every 12 hours for at least 5 days, followed by warfarin, begun concomitantly, for 6 months.
https://acphospitalist.acponline.org/weekly/archives/2015/12/09/4.htm
9 Dec 2015
Who should receive inferior vena cava filters?
Consults, new data can help hospitalists decide.
https://acphospitalist.acponline.org/archives/2016/08/inferior-vena-cava-filters.htm
15 Aug 2016
IVC filters lower PE death risk vs anticoagulants, but raise recurrent VTE risk
Patients with venous thromboembolism (VTE) and significant bleeding risk who got inferior vena cava (IVC) filters had a lower risk of pulmonary embolism (PE)-related death, but a higher risk of recurrent VTE than those on anticoagulants only, a study found.
https://acphospitalist.acponline.org/weekly/archives/2014/03/12/3.htm
12 Mar 2014
Reducing unnecessary PPI use may help save lives
Follow guidelines and implement electronic systems to improve use.
https://acphospitalist.acponline.org/archives/2016/03/unnecessary-PPIs.htm
15 Mar 2016
Oral anticoagulants compared for risk of recurrent VTE, major bleeds
All oral anticoagulants and antiplatelet agents reduced recurrence of venous thromboembolism (VTE) compared with placebo, with aspirin reducing risk the least and vitamin K antagonists reducing it the most, a meta-analysis found.
https://acphospitalist.acponline.org/weekly/archives/2013/09/11/4.htm
11 Sep 2013
Less intensive warfarin therapy less effective at preventing VTE after arthroplasty
Rates of major bleeding were similar whether patients were treated to an international normalized ratio target of 1.8 or 2.5 to prevent venous thromboembolism (VTE) after hip or knee arthroplasty, a randomized trial found.
https://acphospitalist.acponline.org/weekly/archives/2019/09/11/4.htm
11 Sep 2019
April 19, 2023
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
https://acphospitalist.acponline.org/archives/2023/04/19/